Abstract:Cancer is a borderless global health challenge that continues to threaten human health. Studies have found that oxidative stress (OS) is often associated with the etiology of many diseases, especially the aging process and cancer. Involved in the OS reaction as a key transcription factor, Nrf2 is a pivotal regulator of cellular redox state and detoxification. Nrf2 can prevent oxidative damage by regulating gene expression with antioxidant response elements (ARE) to promote the antioxidant response process. OS is generated with an imbalance in the redox state and promotes the accumulation of mutations and genome instability, thus associated with the establishment and development of different cancers. Nrf2 activation regulates a plethora of processes inducing cellular proliferation, differentiation and death, and is strongly associated with OS-mediated cancer. What's more, Nrf2 activation is also involved in anti-inflammatory effects and metabolic disorders, neurodegenerative diseases, and multidrug resistance. Nrf2 is highly expressed in multiple human body parts of digestive system, respiratory system, reproductive system and nervous system. In oncology research, Nrf2 has emerged as a promising therapeutic target. Therefore, certain natural compounds and drugs can exert anti-cancer effects through the Nrf2 signaling pathway, and blocking the Nrf2 signaling pathway can reduce some types of tumor recurrence rates and increase sensitivity to chemotherapy. However, Nrf2's dual role and controversial impact in cancer are inevitable consideration factors when treating Nrf2 as a therapeutic target. In this review, we summarized the current state of biological characteristics of Nrf2 and its dual role and development mechanism in different tumor cells, discussed Keap1/Nrf2/ARE signaling pathway and its downstream genes, elaborated the expression of related signaling pathways such as AMPK/mTOR and NF-κB. Besides, the main mechanism of Nrf2 as a cancer therapeutic target and the therapeutic strategies using Nrf2 inhibitors or activators, as well as the possible positive and negative effects of Nrf2 activation were also reviewed. It can be concluded that Nrf2 is related to OS and serves as an important factor in cancer formation and development, thus provides a basis for targeted therapy in human cancers.

Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases

Perspectives on the Clinical Development of NRF2-Targeting Drugs

KEAP1, a cysteine-based sensor and a drug target for the prevention and treatment of chronic disease

KEAP1-NRF2 protein-protein interaction inhibitors: Design, pharmacological properties and therapeutic potential

Advances and challenges in therapeutic targeting of NRF2

The KEAP1-NRF2 pathway: Targets for therapy and role in cancer

Molecular Basis of the KEAP1-NRF2 Signaling Pathway

Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach

Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers

Modulation of NRF2: biological dualism in cancer, targets and possible therapeutic applications

Modulation of NRF2 signaling pathway by nuclear receptors: implications for cancer.

Nrf2/Keap1/ARE signaling: Towards specific regulation

Nrf2 Signaling Pathway: Pivotal Roles in Inflammation.

“NRF2 Addiction” in Lung Cancer Cells and Its Impact on Cancer Therapy

Epigenetic Therapeutics Targeting NRF2/KEAP1 Signaling in Cancer Oxidative Stress

Nrf2 activation in the treatment of neurodegenerative diseases: a focus on its role in mitochondrial bioenergetics and function

Mechanistic Studies of the Nrf2-Keap1 Signaling Pathway

Electrophilic metabolites targeting the KEAP1/NRF2 partnership

Molecular mechanisms and systemic targeting of NRF2 dysregulation in cancer

Potential Applications of NRF2 Inhibitors in Cancer Therapy

Redefining Neurodegenerative Treatment: Synergy of KEAP1, PROTACs, and Inflammatory Modulators